abvc-logo-nasdaq-440x386 (1).png
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
March 14, 2024 09:30 ET | ABVC BioPharma, Inc.
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a biotechnology company specializing in botanically based solutions that deliver...
abvc-logo-nasdaq-440x386 (1).png
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
February 08, 2024 09:17 ET | ABVC BioPharma, Inc.
FREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Yiviva and AstraZeneca Strategic Collaboration Memorandum Signing Ceremony
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach
February 05, 2024 09:00 ET | Yiviva
NEW YORK and SHANGHAI, China, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed...
Research Nester Logo.jpg
Blood Group Typing Market revenue to hit USD 2 Billion by 2033, says Research Nester
February 05, 2024 06:00 ET | Research Nester
New York , Feb. 05, 2024 (GLOBE NEWSWIRE) -- The global blood group typing market size is slated to expand at 7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 2 billion...
Global Healthcare Data Collection and Labelling Market
Global Healthcare Data Collection and Labelling Market (2023-2028): Projected to Attain USD 1914.41 Mn by 2028 with Robust CAGR of 25.09%
February 05, 2024 04:44 ET | Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Healthcare Data Collection and Labelling Market (2023-2028) by Data Type, End-Users, and Geography, Competitive Analysis, Impact of Covid-19,...
Emergen logo.png
Viscosupplementation Market Size Worth USD 10.51 Billion in 2032 | Emergen Research
January 22, 2024 12:15 ET | Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global viscosupplementation market size reached USD 4.41 Billion in 2022 and is expected to register a revenue CAGR of 9.1% during the forecast...
logo.png
Protein Engineering Market Size Estimated to Reach USD 15.25 Bn by 2032
January 05, 2024 10:40 ET | Precedence Research
Ottawa, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The global protein engineering market size was valued at USD 3.72 billion in 2023, grew to USD 4.35 billion in 2024 and the industry is expected to grow at...
AIVAVA BIOPHARMA COLOR.png
AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors
August 29, 2023 19:00 ET | AiViva Biopharma
COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today...
GMILogo_Vertical-Gradient.png
Flip Chip Market to surpass $60 Bn by 2032, Says Global Market Insights inc.
August 15, 2023 19:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Flip Chip Market is projected to be worth more than USD 60 billion by the end of 2032, as per a recent study by Global Market Insights Inc. ...
VaxxCheck500x500px.png
Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease
August 10, 2023 08:00 ET | Vaxxinity, Inc.
Phase 2a data published in The Lancet’s eBioMedicine supports further development of UB-311 The paper concludes that UB-311 is the most advanced active immunotherapy targeting beta-amyloid in the...